[35] Our observations could provide a rationale for the clinical use of the AFP serotest coupled with US screening, particularly in the cirrhotic subjects, in order to provide life-saving or life-extending opportunities to impending HCC patients. Here, AFP is linked to hepatocellular carcinoma.